PRELUDE CAPITAL MANAGEMENT, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 232 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$5,374,000
-28.2%
35,549
-30.8%
0.19%
-9.4%
Q2 2022$7,484,000
+4697.4%
51,361
+2313.6%
0.21%
+2266.7%
Q2 2020$156,000
-37.3%
2,128
-53.5%
0.01%0.0%
Q4 2019$249,000
+352.7%
4,581
+243.4%
0.01%
+350.0%
Q3 2019$55,000
-93.6%
1,334
-93.3%
0.00%
-95.2%
Q2 2019$866,000
+95.5%
19,769
+129.8%
0.04%
+68.0%
Q1 2019$443,000
+5437.5%
8,603
+3977.3%
0.02%
Q3 2018$8,000
-99.2%
211
-99.5%
0.00%
-100.0%
Q1 2018$1,023,00039,7000.07%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 710,422$24,658,74716.62%
Birchview Capital, LP 7,365$255,6390.24%
Itau Unibanco Holding S.A. 88$3,0540.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders